Digital Oral Presentation Session 2 - New tips for clinical practice

  • 17:45-18:45 Digital Oral Presentation Session 2 – New tips for clinical practice
    Chairs:
    Jane Andrews, Adelaide, Australia
    Glen Doherty, Dublin, Ireland
       17:45-17:51 DOP010: ECCO Topical Review on Transitional Care in Inflammatory Bowel Disease

    van Rheenen, P., ECCO Transition Topical Review Consensus Group
    University Medical Center Groningen, Pediatric Gastroenterology, Groningen, Netherlands
      17:51-17:57 DOP011: Risk of opportunistic infection in healthcare personnel with Inflammatory Bowel Disease: A case-control study of the GETAID

    Gagniere, C.1, Bourrier, A.2, Seksik, P.2, Gornet, J.-M.3, Dewit, O.4, Nancey, S.5, Altwegg, R.6, Abitbol, V.7, Laharie, D.8, Reenaers, C.9, Buisson, A.10, Nachury, M.11, Viennot, S.12, Vuitton, L.13, Stefanescu, C.14, Marteau, P.15, Bouguen, G.16, Cosnes, J.2, Amiot, A.1

    1Henri Mondor Hospital, Gastroenterology, Creteil, France, 2APHP St. Antoine Hospital, Department of Gastroenterology, Paris, France, 3Hospital Saint-Louis, Department of Gastroenterology, Paris, France, 4UCL Saint-Luc, Department of Gastroenterology, Brussels, Belgium, 5Hospital Edouard Herriot, Department of Gastroenterology and Hepatology, Lyon, France, 6CHU Montpellier Saint Eloi Hospital, Department of Gastroenterology, Montpellier, France, 7Cochin Hospital, Department of Gastroenterology, Paris, France, 8CHU Bordeaux, Department of Gastroenterology, Bordeaux, France, 9CHU Liège, Sart Tilman, Department of Gastroenterology, Liège, Belgium, 10CHU Estaing, Department of Gastroenterology, Clermont-Ferrand, France, 11CHRU Lille, Department of Gastroenterology, Lille, France, 12Hospital Cote de Nacre, Department of Gastroenterology, Caen Cede, France, 13CHU Besancon, Department of Gastroenterology and Hepatology, Besançon, France, 14APHP Beaujon, Department of Gastroenterology, Clichy, France, 15Hospital Lariboisière, Department of Gastroenterology, Paris, France, 16CHU Pontchaillou, Department of Gastroenterology, Rennes, France
      17:57-18:03 DOP012: Impact on clinical practice of Epstein-Barr virus infection in patients with Inflammatory Bowel Disease

    de Francisco, R.
    1, Riestra, S.1, Pérez-Martínez, I.1, Castaño, A.1, Martínez-González, S.1, Jiménez, S.2, González, A.J.3, Morais, L.R.3, Suárez, A.1

    1Hospital Universitario Central de Asturias, Gastroenterology, Oviedo, Spain, 2Hospital Universitario Central de Asturias, Pediatrics, Oviedo, Spain, 3Hospital Universitario Central de Asturias, Hematology, Oviedo, Spain
      18:03-18:09 DOP013: Definition of therapeutic response criteria using MRI in Crohn’s Disease patients treated with anti-TNF therapy: A multicenter prospective study (the IRMA study)

    Buisson, A.
    1,2, Messadeg, L.3, Bouguen, G.4, Goutorbe, F.1,5, Reimund, J.-M.6, Goutte, M.1,2, Sautel, C.7, Duron, C.8, Scanzi, J.1, Reymond, M.1, Allimant, C.1, Dapoigny, M.1, Bommelaer, G.1,2, Pereira, B.9, Hordonneau, C.3

    1University Hospital Estaing, Gastroenterology Department, Clermont-Ferrand, France, 2UMR 1071 Inserm/Université d'Auvergne; USC-INRA 2018, Microbes, Intestine, Inflammation and Susceptibility of the host, Clermont-Ferrand, France, 3University Hospital Estaing, Radiology Department, Clermont-Ferrand, France, 4University Hospital, Rennes, France, 5Hospital of Bayonne, Gastroenterology Department, Bayonne, France, 6University Hospital Hautepierre, Gastroenterology Department, Strasbourg, France, 7Hospital of Issoire, Gastroenterology Department, Issoire, France, 8Hospital of Montluçon, Department of Gastroenterology, Montluçon, France, 9University Hospital, Biostatistics Unit, DRCI, Clermont-Ferrand, France
      18:09-18:15 DOP014: Transmural healing is better than mucosal healing in Crohn's Disease

    Raimundo Fernandes, S.1, Vale Rodrigues, R.2, Bernardo, S.1, Cortez Pinto, J.2, Rosa, I.2, Correia, L.1, Moura Santos, P.3, Rita Gonçalves, A.3, Valente, A.3, Baldaia, C.3, Pereira da Silva, J.2, Dias Pereira, A.2, Velosa, J.1
    1Hospital de Santa Maria, Serviço de Gastrenterologia e Hepatologia, Lisboa, Portugal, 2Instituto Português de Oncologia de Lisboa, Serviço de Gastrenterologia, Lisboa, Portugal, 3Centro Hospitalar Lisboa Norte, Gastrenterology, Lisbon, Portugal
      18:15-18:21 DOP015: International differences in gastroenterologists’ perspective on stopping therapy for patients with Crohn’s Disease

    Siegel, C.A.
    1, Thompson, K.D.1, Walls, D.2, Gollins, J.3, Colombel, J.-F.4, Louis, E.5, On behalf of the BIOCYCLE group5

    1Dartmouth-Hitchcock Medical Center, Lebanon, United States, 2BDJ Solutions, Boston, United States, 3Delta Modelling, Chicago, United States, 4Icahn School of Medicine at Mount Sinai, New York, United States, 5University Hospital CHU of Liège, Liège, Belgium
       18:21-18:27 DOP016: Long-term safety of in utero exposure to anti-tumor necrosis factor for the treatment of Inflammatory Bowel Diseases: Results from the multicenter European TEDDY study

    Chaparro, M.1, Verreth, A.2, Lobaton, T.3, Gravito-Soares, E.4, Julsgaard, M.5, Savarino, E.6, Magro, F.7, Avni Biron, I.8, López-Serrano, P.9, Casanova, M.1, Gompertz, M.10, Vitor, S.11, Arroyo, M.12, Pugliese, D.13, Zabana, Y.14, Vicente, R.15, Aguas, M.16, Bar-Gil Shitrit, A.17, Gutierrez, A.18, Doherty, G.19, Fernández-Salazar, L.20, Martinez Cadilla, J.21, Huguet, J.22, O´Toole, A.23, Stasi, E.24, Manceñido Marcos, N.25, Villoria, A.26, Karmiris, K.27, Rahier, J.28, Rodriguez, C.29, Diz-Lois Palomares, M.30, Fiorino, G.31, Benítez, J.32, Principi, M.33, Naftali, T.34, Taxonera, C.35, Mantzaris, G.36, Sebkova, L.37, Iade, B.38, Lissner, D.39, Ferrer Bradley, I.40, López-San Román, A.41, Marín-Jiménez, I.42, Merino, O.43, Sierra, M.44, Van Domselaar, M.45, Caprioli, F.46, Guerra, I.47, Peixe, P.48, Piqueras, M.49, Rodríguez-Lago, I.50, Ber, Y.51, Van Hoeve, K.2, Torres, P.3, Gravito-Soares, E.4, Rudbeck-Thomsen, D.5, Bartolo, O.6, Peixoto, A.7, Martín, G.8, Pérez, J.1, Garre, A.1, G Donday, M.1

    1Hospital Universitario de La Princesa, IIS-IP and CIBERehd, Madrid, Spain, 2University Hospitals Leuven, Leuven, Belgium, 3Hospital Universitari Germans Trias i Pujol, Badalona, Spain, 4Centro Hopitalar e Universitario de Coimbra, Coimbra, Portugal, 5Aarhus University Hospital, Aarhus, Denmark, 6University of Padua, Padua, Italy, 7Centro Hospitalar Sao Joao, Porto, Portugal, 8Rabin Medical Center, Petaj Tikva, Israel, 9Hospital Universitario Fundación Alcorcón, Alcorcón, Spain, 10Hospital Clinic Barcelona, Barcelona, Spain, 11Hospital de Santa Maria de Lisboa, Lisboa, Portugal, 12Hospital Clínico de Zaragoza, Zaragoza, Spain, 13Complesso Integrato Columbus Catholic University, Roma, Italy, 14Hospital Universitari Mútua de Terrassa, Terrassa, Spain, 15Hospital Universitario Miguel Servet, Zaragoza, Spain, 16Hospital Universitario La Fe, Valencia, Spain, 17Shaare Zedek Medical Center Jerusalem, Jerusalem, Israel, 18Hospital General Universitario de Alicante, Alicante, Spain, 19St. Vincents University Hospital, Dublin, Ireland, 20Hospital Clínico Universitario de Valladolid, Spain, Valladolid, Spain, 21Hospital Universitario Alvaro Cunqueiro, Vigo, Spain, 22Hospital General Universitario de Valencia, Valencia, Spain, 23Beaumont Hospital, Dublin, Ireland, 24IRCCS Saverio de Bellis, Castellana Grotte, Italy, 25Hospital Infanta Sofía, Madrid, Spain, 26Hospital Parc Taulí, Sabadell, Spain, 27Venizeleio General Hospital, Heraklion, Greece, 28CHU Dinant Godinne, Dinant, Belgium, 29Complejo Universitario de Navarra, Pamplona, Spain, 30Hospital Universitario A Coruña, Coruña, Spain, 31Humanitas Research Hospital, Milan, Italy, 32Hospital Reina Sofia, Córdoba, Spain, 33Azienda Ospedaliera Policlinico de Bari, Bari, Italy, 34Meir Hospital Kfar saba Tel Aviv University, Tel Aviv, Israel, 35Hospital Clínico San Carlos, Madrid, Spain, 36Evangelismos, Ophthalmiatreion Athinon and Polyclinic Hospitals, Athens, Greece, 37Azienda Ospedaliera 'Pugliese-Ciaccio", Catanzaro, Italy, 38Hospital de Clínicas, Montevideo, Uruguay, 39Universitätsmedizin Berlin, Campus Benjamin Franklin, Berlin, Germany, 40Hospital de Manises, Manises, Spain, 41Hospital Ramón y Cajal, Madrid, Spain, 42Hospital General Universitario Gregorio Marañon, Madrid, Spain, 43Hospital Universitario de Cruces, Baracaldo, Spain, 44Hospital de León, León, Spain, 45Hospital de Torrejón, Torrejón de Ardoz, Spain, 46IRCCS Ospedale Ca Granda Policlinico di Milano, Milano, Italy, 47Hospital Universitario de Fuenlabrada, Fuenlabrada, Spain, 48Centro Hospitalar Lisboa Ocidental, Lisboa, Portugal, 49Consorci Sanitari de Terrasa, Terrasa, Spain, 50Hospital de Galdakao, Vizcaya, Spain, 51Hospital San Jorge, Huesca, Spain
       18:27-18:33 DOP017: Patterns of anti-TNF use and associated treatment outcomes in Inflammatory Bowel Disease patients: Results from an analysis of Dutch health insurance claims data

    Bots, S.
    1, Hoekman, D.1,2, Benninga, M.2, Ponsioen, C.1, Smeets, H.3, D'Haens, G.1, Löwenberg, M.1

    1Academic Medical Center (AMC), Department of Gastroenterology and Hepatology, Amsterdam, Netherlands, 2Academic Medical Center (AMC), Department of Pediatric Gastroenterology and Nutrition, Amsterdam, Netherlands, 3Achmea Health Insurance, Amersfoort, Netherlands
      18:33-18:39 DOP018: Effect of adalimumab on extraintestinal manifestations among patients with Ulcerative Colitis in a clinical practice setting: Results from INSPIRADA

    Travis, S.1, Feagan, B.2, Peyrin-Biroulet, L.3, Panaccione, R.4, Danese, S.5, Lazar, A.6, Robinson, A.7, Thakkar, R.7, Pappalardo, B.7, Petersson, J.7, Bereswill, M.6, Chen, N.7, Skup, M.7

    1Oxford University Hospitals, Oxford, United Kingdom, 2Robarts Research Institute, London, Canada, 3University Hospital of Nancy, Les Nancy, France, 4University of Calgary, Calgary, Canada, 5Istituto Clinico Humanitas, Milan, Italy, 6AbbVie Deutschland GmbH & Co. KG, Ludwigshafen, Germany, 7AbbVie Inc., North Chicago, United States